The COVID-19 pandemic is a lethal virus outbreak by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which has severely affected human lives and the global economy. The most vital part of the research and development of therapeutic agents is to design drug products to manage COVID-19 efficiently. Numerous attempts have been in place to determine the optimal drug dose and combination of drugs to treat the disease on a global scale. This article documents the information available on SARS-CoV-2 and its life cycle, which will aid in the development of the potential treatment options. A consolidated summary of several natural and repurposed drugs to manage COVID-19 is depicted with summary of current vaccine development. People with high age, comorbity and concomitant illnesses such as overweight, metabolic disorders, pulmonary disease, coronary heart disease, renal failure, fatty liver and neoplastic disorders are more prone to create serious COVID-19 and its consequences. This article also presents an overview of post-COVID-19 complications in patients. Plain language summary Severe acute respiratory syndrome coronavirus-2 causes the coronavirus disease i.e., COVID-19. This article encompasses basic information about coronavirus and COVID-19. It includes information about viral transmission and subsequent events for COVID-19 in a person, and it presents different drugs and vaccines utilized for the management of COVID-19. Several natural drugs are proposed to manage COVID-19. It also has an overview about post-COVID-19 complications in recovered patients.
【저자키워드】 COVID-19, Drug repurposing, SARS-CoV-2, coronavirus, pandemic, Vaccines, drug target, drug discovery process, 【초록키워드】 coronavirus disease, Vaccine, Vaccine development, coronavirus, Repurposed drugs, COVID-19 pandemic, research and development, severe acute respiratory syndrome coronavirus-2, drug, severe acute respiratory syndrome Coronavirus, virus, Repurposed drug, Severe acute respiratory syndrome, Consequences, Viral, outbreak, management, Research, Complication, age, therapeutic agent, Viral transmission, therapeutic agents, Fatty liver, recovered patients, respiratory, information, patients, pulmonary disease, Coronavirus-2, renal failure, Coronary heart disease, heart disease, overweight, life cycle, Metabolic disorders, acute respiratory syndrome, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus-2, serious COVID-19, treat, disorder, renal, event, affected, include, subsequent, the disease, determine, cause, illness, Numerous, drug dose, fatty, 【제목키워드】 therapeutic, Perspective,